Zebra Technologies
ZBRA
$249.30
-2.02%
Zebra Technologies Corporation is a leading provider of automatic identification and data capture (AIDC) technology, offering hardware and software solutions such as barcode printers, scanners, mobile computers, and workflow optimization software primarily to the retail, transportation logistics, manufacturing, and healthcare industries. The company is a dominant market leader in enterprise asset intelligence, distinguished by its comprehensive portfolio that bridges physical assets with digital data streams to optimize operational efficiency. The current investor narrative is driven by a volatile mix of strong growth potential signaled by bullish guidance, as evidenced by a recent 20% single-day stock surge, juxtaposed against broader macroeconomic pressures from persistent inflation and rising interest rates that have weighed on technology valuations.…
ZBRA
Zebra Technologies
$249.30
Related headlines
Investment Opinion: Should I buy ZBRA Today?
Rating & Thesis: Hold. ZBRA presents a high-risk, high-reward proposition where the potential for an earnings-driven rebound is counterbalanced by severe near-term margin pressures and macro headwinds; the stock is best suited for patient, risk-tolerant investors awaiting a confirmation of the turnaround. While analyst sentiment leans bullish with 'Outperform' and 'Overweight' ratings, the limited coverage (5 analysts) and lack of a consensus price target necessitate caution.
Supporting Evidence: The primary valuation metric, the forward P/E of 11.77x, is compelling if the estimated EPS of $29.40 is achieved, implying significant earnings growth from the depressed Q4 level. However, this is challenged by a 10.57% YoY revenue growth that is showing signs of deceleration and a net margin that has compressed from 12.22% to 4.75%. The robust TTM free cash flow of $831 million and active share buybacks are positive signals of financial health. The stock's current price near the lower end of its 52-week range suggests much bad news is priced in, but not all.
Risks & Conditions: The two biggest risks are 1) the failure of margins to recover, invalidating forward earnings estimates, and 2) further multiple compression if interest rates remain elevated. This Hold rating would upgrade to a Buy if quarterly gross margins stabilize above 46% and operating income shows sequential growth, confirming the recovery thesis. It would downgrade to a Sell if revenue growth decelerates below 5% YoY or the stock breaks decisively below its 52-week low of $199.05. Relative to its own history and sector, ZBRA is in a state of transition—neither clearly overvalued nor undervalued—but fairly valued for the significant execution risk it carries.
Sign up to view all
ZBRA 12-Month Price Forecast
The outlook for ZBRA is bifurcated, hinging entirely on the resolution of its margin trajectory. The base case (50% probability) of a choppy recovery toward analyst EPS targets is most likely, offering modest upside to the $270-$300 range. The bull case requires flawless execution and a supportive macro backdrop, while the bear case remains a tangible threat given the stock's proximity to its 52-week low. The AI assessment is neutral due to the high degree of binary uncertainty; the compelling forward valuation is directly contradicted by deteriorating current fundamentals. The stance would upgrade to bullish on concrete evidence of margin stabilization (e.g., two consecutive quarters of gross margin expansion) and downgrade to bearish on a breakdown below the $199 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Zebra Technologies's 12-month outlook, with a consensus price target around $324.09 and implied upside of +30.0% versus the current price.
Average Target
$324.09
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$199 - $324
Analyst target range
Analyst coverage for ZBRA is limited, with only 5 analysts providing estimates, indicating this is a mid-cap stock with less institutional scrutiny which can lead to higher volatility and less efficient price discovery. The consensus sentiment leans bullish, as evidenced by recent institutional ratings including 'Outperform' from Baird and 'Overweight' from Barclays, though there are also 'Neutral' and 'Hold' ratings from Citigroup and Truist Securities. Specific consensus price target and Buy/Hold/Sell distribution data are not available in the provided dataset, preventing calculation of implied upside or downside to a consensus target. The target range can be inferred from earnings estimates, with a high EPS estimate of $29.80 and a low of $29.00, reflecting a tight band and relatively high conviction in near-term earnings, though this does not directly translate to price targets. The wide dispersion in recent stock price action, contrasted with tight EPS estimates, signals that the primary uncertainty lies in the multiple the market will assign to those earnings rather than the earnings themselves, driven by macro concerns and sector rotation.
Bulls vs Bears: ZBRA Investment Factors
The investment debate for ZBRA is a classic tension between forward-looking optimism and present-day operational challenges. The bull case is anchored in a compelling valuation reset, with the forward P/E at 11.77x pricing in a robust earnings recovery, strong free cash flow supporting shareholder returns, and a recent guidance-driven surge proving latent positive catalysts exist. The bear case is grounded in harsh reality: severe margin compression, a clear technical downtrend, and decelerating revenue growth amidst a tough macro backdrop. Currently, the bearish evidence holds stronger sway, as the margin deterioration is severe, quantifiable, and ongoing, while the bullish recovery remains a forecast. The single most important tension is whether management can execute a margin recovery to meet the forward earnings estimates ($29.40 EPS) that justify the current price, or if persistent cost pressures and weak demand will lead to further estimate cuts and multiple compression.
Bullish
- Strong Forward Earnings Recovery Priced In: The forward P/E of 11.77x is less than half the trailing P/E of 29.45x, reflecting market expectations for a significant earnings rebound. Analyst EPS estimates for the next year average $29.40, indicating a clear path to profitability normalization from the Q4 2025 net margin of 4.75%.
- Robust Free Cash Flow Generation: The company generates substantial free cash flow, with TTM FCF of $831 million. This provides a strong financial foundation, evidenced by $303 million in stock buybacks in Q4 2025, signaling management confidence and a commitment to shareholder returns.
- Bullish Guidance Catalyzed Recent Surge: The stock surged 20% on February 12, 2026, following bullish guidance that exceeded analyst expectations. This event demonstrates underlying operational strength and growth potential that can override near-term margin pressures when communicated positively.
- Valuation at Lower End of Historical Range: The current trailing P/E of 29.45x is well below the historical high of over 206x and sits in the lower-middle of its own historical band. This suggests significant pessimism is already priced in, leaving room for multiple expansion if execution improves.
Bearish
- Severe Margin Compression Across All Lines: Profitability is deteriorating sharply, with Q4 2025 net margin collapsing to 4.75% from 12.22% a year ago. Gross margin also fell to 44.61% from 48.58%, indicating persistent cost inflation and pricing pressure that threatens the earnings recovery thesis.
- Pronounced Long-Term Downtrend and High Volatility: The stock is in a clear downtrend, down 16.71% over the past year and trading near the bottom 16% of its 52-week range. A beta of 1.624 means it is 62% more volatile than the market, amplifying downside risk during sell-offs.
- Revenue Growth Shows Signs of Deceleration: While Q4 2025 revenue grew 10.57% YoY, it followed a sequential decline from Q3 and comes from a volatile, choppy multi-quarter trend. This suggests growth momentum is slowing, potentially due to macroeconomic pressures on enterprise capex.
- Trailing Valuation Premium to Sector: A trailing P/E of 29.45x trades at a premium to the typical Communication Equipment sector average in the low 20s. This premium is difficult to justify given the current margin compression and growth deceleration, creating valuation compression risk.
ZBRA Technical Analysis
The prevailing price trend for ZBRA is a pronounced downtrend, characterized by a 1-year price change of -16.71% and a current price of $243.63, which sits at just 16.1% of its 52-week range (between $199.05 and $352.66). This positioning near the lower bound of the range suggests the stock is in a deep value territory but also reflects significant bearish momentum and investor pessimism, indicating it could be a falling knife rather than a clear value opportunity. Recent short-term momentum shows a sharp but volatile recovery, with a 1-month price increase of 13.03% and a 3-month gain of 8.78%, which diverges positively from the longer-term downtrend. However, this recovery has been highly erratic, as seen in the price data with large single-day swings, and the stock's 1-month relative strength of +6.72% against the SPY's +6.31% indicates it has only marginally outperformed the market during this bounce. Key technical levels are clearly defined, with immediate support at the 52-week low of $199.05 and major resistance at the 52-week high of $352.66. A sustained breakdown below $199 would signal a continuation of the bear trend, while a move above the recent recovery highs near $274 is needed to suggest a more durable reversal. The stock's beta of 1.624 confirms it is 62% more volatile than the broader market, which amplifies both upside and downside moves and necessitates larger risk buffers for position sizing.
Beta
1.62
1.62x market volatility
Max Drawdown
-41.6%
Largest decline past year
52-Week Range
$199-$353
Price range past year
Annual Return
-14.6%
Cumulative gain past year
| Period | ZBRA Return | S&P 500 |
|---|---|---|
| 1m | +11.4% | +5.0% |
| 3m | +8.5% | +10.7% |
| 6m | -5.9% | +10.0% |
| 1y | -14.6% | +26.5% |
| ytd | +0.4% | +10.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ZBRA Fundamental Analysis
Zebra's revenue trajectory shows growth but with signs of deceleration and volatility; Q4 2025 revenue was $1.475 billion, representing a 10.57% year-over-year increase, yet this follows a sequential decline from Q3's $1.32 billion. Segment data reveals the Enterprise Visibility & Mobility (EVM) segment, at $865 million, is the larger revenue driver compared to the Asset Intelligence Tracking (AIT) segment at $455 million, though specific growth rates per segment are not available. The multi-quarter trend indicates revenue peaked in Q1 2025 at $1.308 billion and has been choppy since, suggesting growth momentum may be slowing amid a tougher macroeconomic environment for enterprise capital expenditure. Profitability is present but under pressure, with Q4 2025 net income of $70 million and a net margin of 4.75%, a significant compression from the 12.22% net margin in Q4 2024. Gross margin for the latest quarter was 44.61%, down from 48.58% a year ago, indicating cost inflation or pricing pressures, while operating margin also contracted to 15.05% from 16.87% year-over-year. The trend over recent quarters shows net income declining from $136 million in Q1 2025 to $70 million in Q4 2025, highlighting a clear margin compression cycle that challenges the investment case despite top-line growth. The balance sheet and cash flow position shows a company with moderate leverage and strong cash generation; the debt-to-equity ratio is 0.78, indicating a manageable capital structure, and the current ratio is 0.97, suggesting adequate but not excessive short-term liquidity. Trailing twelve-month free cash flow is a robust $831 million, providing ample internal funding for growth initiatives and share repurchases, as evidenced by $303 million in stock buybacks in Q4 2025, while the return on equity of 11.68% reflects acceptable but not stellar capital efficiency.
Quarterly Revenue
$1.5B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.44%
Latest Quarter
Free Cash Flow
$831000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ZBRA Overvalued?
Given that net income is positive ($70 million in Q4 2025), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 29.45x, while the forward PE is significantly lower at 11.77x, indicating the market expects a substantial recovery in earnings over the next year, aligning with analyst EPS estimates averaging $29.40. Compared to industry averages, ZBRA's trailing PE of 29.45x trades at a premium to the Communication Equipment sector average PE, which typically ranges in the low 20s, though a precise industry average from the provided data is not available for a quantified spread. This premium may be partially justified by Zebra's market leadership and strong free cash flow generation, but it is challenged by the current margin compression and growth deceleration evident in the fundamentals. Historically, the stock's own valuation has contracted sharply; the current trailing PE of 29.45x is below the historical high of over 206x seen in late 2023 but above the low of 17.80x from late 2022. This places the valuation in the lower-middle range of its own historical band, suggesting the market has priced in significant pessimism regarding the earnings downturn but not necessarily pricing in a catastrophic scenario, leaving room for multiple expansion if execution improves.
PE
29.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -202x~206x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary risk is the severe and ongoing margin compression, with Q4 2025 net income falling to $70 million from $136 million in Q1 2025, representing a 49% decline. Gross margin contraction from 48.58% to 44.61% year-over-year indicates the company is struggling to pass on cost inflation, which could persist and derail the expected earnings recovery. Furthermore, while free cash flow is strong, the current ratio of 0.97 suggests liquidity is adequate but tight, limiting financial flexibility in a downturn. The company's growth narrative is dependent on a rebound in enterprise capital expenditure, which remains vulnerable to a macroeconomic slowdown.
Market & Competitive Risks: ZBRA faces significant valuation compression risk, as its trailing P/E of 29.45x sits at a premium to its sector peers. In a rising rate environment that penalizes premium valuations, this multiple could contract further. The stock's high beta of 1.624 confirms it is highly sensitive to broader market swings, particularly tech sector rotations. Recent news highlights stubborn inflation keeping Fed rates high, a direct headwind for growth-oriented tech stocks. Competitively, while ZBRA is a market leader, the industry is evolving, and the news of a peer (Brady Corp) transforming via AI and acquisitions underscores the risk of technological disruption if ZBRA fails to innovate.
Worst-Case Scenario: The worst-case scenario involves a continuation of the margin erosion coupled with a macroeconomic recession that cripples enterprise spending. This would lead to consecutive earnings misses, analyst downgrades, and a derating of the forward P/E multiple. In this adverse scenario, the stock could realistically re-test its 52-week low of $199.05, representing a downside of approximately -18% from the current price of $243.63. Given the stock's historical max drawdown of -41.62% and high volatility, a break below this support could trigger a steeper decline towards the $180-$190 range, implying a total loss of -26% to -34% for investors.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Continued margin compression, as seen in the net margin drop from 12.22% to 4.75% YoY, which could derail earnings estimates. 2) Market Risk: Valuation compression due to its premium trailing multiple (29.45x) in a high-rate environment, amplified by its high beta of 1.624. 3) Operational Risk: Decelerating revenue growth and vulnerability to cuts in enterprise capital expenditure. 4) Liquidity Risk: While FCF is strong, the current ratio of 0.97 indicates limited short-term liquidity buffer.
The 12-month forecast is highly scenario-dependent. The base case (50% probability) sees a choppy recovery leading to a price range of $270-$300, driven by EPS meeting the $29.40 consensus. The bull case (30% probability) involves a strong margin rebound and multiple expansion, targeting the $330-$352 range. The bear case (20% probability) involves failed execution and a retest of the 52-week low near $199. The most likely outcome is the base case, but it hinges on the critical assumption that quarterly gross margins stop declining in the next earnings report.
ZBRA's valuation is schizophrenic, presenting both overvaluation and undervaluation depending on the timeframe. Based on trailing earnings (P/E of 29.45x), it trades at a premium to its sector peers, suggesting overvaluation given its deteriorating profitability. However, based on forward earnings estimates (P/E of 11.77x), it appears deeply undervalued, implying the market expects a dramatic profit rebound. The stock is fairly valued for the significant execution risk it carries. The current price implies the market is paying a discount for future growth but demands proof that margins can recover.
ZBRA is a speculative buy, not a core holding. For risk-tolerant investors seeking a turnaround story, the forward P/E of 11.77x offers compelling value if the company can execute an earnings recovery to the $29.40 EPS estimate. However, it carries significant risk, with a high beta of 1.624 and severe margin compression that must be reversed. It could be a good buy for a patient investor willing to accept potential further downside to the $199 support level in exchange for the asymmetric upside if the recovery thesis plays out. Conservative investors should avoid it until margin trends clearly improve.
ZBRA is unsuitable for short-term trading due to its high volatility (beta 1.624) and lack of clear near-term catalysts beyond earnings reports. It is best considered a medium-to-long-term (2-3 year) investment for investors betting on a full business cycle recovery. The thesis requires time for management to implement cost controls, for macro pressures to ease, and for earnings to normalize. The absence of a dividend further removes any incentive for short-term income generation. A minimum holding period of 12-18 months is suggested to allow the recovery narrative time to unfold or fail.